Title |
Zinc supplements for treating thalassaemia and sickle cell disease
|
---|---|
Published in |
Cochrane database of systematic reviews, June 2013
|
DOI | 10.1002/14651858.cd009415.pub2 |
Pubmed ID | |
Authors |
Kye Mon Min Swe, Adinegara BL Abas, Amit Bhardwaj, Ankur Barua, N S Nair |
Abstract |
Haemoglobinopathies, inherited disorders of haemoglobin synthesis (thalassaemia) or structure (sickle cell disease), are responsible for significant morbidity and mortality throughout the world. The WHO estimates that, globally, 5% of adults are carriers of a haemoglobin condition, 2.9% are carriers of thalassaemia and 2.3% are carriers of sickle cell disease. Carriers are found worldwide as a result of migration of various ethnic groups to different regions of the world. Zinc is an easily available supplement and intervention programs have been carried out to prevent deficiency in people with thalassaemia or sickle cell anaemia. It is important to evaluate the role of zinc supplementation in the treatment of thalassaemia and sickle cell anaemia to reduce deaths due to complications. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 25% |
France | 1 | 13% |
Unknown | 5 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 63% |
Science communicators (journalists, bloggers, editors) | 2 | 25% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Indonesia | 1 | <1% |
Ireland | 1 | <1% |
Unknown | 205 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 39 | 19% |
Student > Bachelor | 27 | 13% |
Researcher | 19 | 9% |
Student > Postgraduate | 16 | 8% |
Student > Ph. D. Student | 16 | 8% |
Other | 42 | 20% |
Unknown | 48 | 23% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 75 | 36% |
Nursing and Health Professions | 23 | 11% |
Agricultural and Biological Sciences | 15 | 7% |
Biochemistry, Genetics and Molecular Biology | 9 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
Other | 23 | 11% |
Unknown | 53 | 26% |